# Synthetic Human Secretin in Children With Autism

> **NCT00036244** · PHASE3 · COMPLETED · sponsor: **Repligen Corporation**

## Conditions studied

- Autism

## Interventions

- **DRUG:** RG1068 (Synthetic Human Secretin)

## Key facts

- **NCT ID:** NCT00036244
- **Lead sponsor:** Repligen Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** — (—)
- **Last updated:** 2005-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036244, "Synthetic Human Secretin in Children With Autism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00036244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*